Heldenbrand, S., Li, C., Cross, R. P., DePiero, K. A., Dick, T. B., Ferguson, K., Kim, M., Newkirk, E., Park, J. M., Sudaria‐Kerr, J., Tichy, E. M., Ueda, K. R., Weng, R., Wisniewski, J., & Gabardi, S. (2016). multicenter evaluation of efficacy and safety of low‐dose versus high‐dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients. Transplant infectious disease, 18(6), 904–912. http://access.bl.uk/ark:/81055/vdc_100039857518.0x000009